Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)
<p>Abstract</p> <p>Background</p> <p>FibroTest and elastography have been validated as biomarkers of liver fibrosis in the most frequent chronic liver diseases and in the fibrosis screening of patients with diabetes. One challenge was to use them for estimating the prev...
Main Authors: | Bismut Françoise, Messous Djamila, Drane Fabienne, Munteanu Mona, Norha Pascal, Ngo Yen, Varsat Brigitte, Varaut Anne, Ingiliz Patrick, Lebray Pascal, Poynard Thierry, Carrau Jean, Massard Julien, Ratziu Vlad, Giordanella Jean |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-04-01
|
Series: | BMC Gastroenterology |
Online Access: | http://www.biomedcentral.com/1471-230X/10/40 |
Similar Items
-
Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age
by: Messous Djamila, et al.
Published: (2011-04-01) -
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease
by: Munteanu Mona, et al.
Published: (2006-02-01) -
An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load.
by: Yen Ngo, et al.
Published: (2008-07-01) -
Correction: An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load
by: Yen Ngo, et al.
Published: (2008-01-01) -
Correction: An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load.
by: Yen Ngo, et al.
Published: (2008-01-01)